Adverse Reactions To Biologics
Download Adverse Reactions To Biologics full books in PDF, epub, and Kindle. Read online free Adverse Reactions To Biologics ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: L. Puig |
Publisher |
: Karger Medical and Scientific Publishers |
Total Pages |
: 120 |
Release |
: 2017-11-07 |
ISBN-10 |
: 9783318061017 |
ISBN-13 |
: 3318061018 |
Rating |
: 4/5 (17 Downloads) |
Synopsis Adverse Reactions to Biologics by : L. Puig
In many areas of medicine physicians still face the great challenge of finding therapies that will meet the patients’ needs. In dermatology the challenge has arisen on multiple fronts through advances in the understanding of the immunopathogenesis of many inflammatory and malignant cutaneous disorders. Breakthroughs, combined with significant developments in targeted immunotherapy, have resulted in improved outcomes as these newer therapies are being used for both approved indications and as off-label therapies for various chronic inflammatory skin disorders and many forms of skin cancer. In the expectation that by truly understanding the safety profile of these targeted therapies patients’ outcomes will be significantly improved, this book offers insights into topics such as adverse reactions, infectious complications and the perioperative use of biologics in psoriasis, immunogenicity of biologic therapies, paradoxical reactions, safety of biologics used to treat autoimmune bullous diseases and primary cutaneous lymphomas, adverse reactions and skin manifestations of therapies targeting melanoma and non-melanoma skin cancer and other neoplastic diseases. Eminent researchers with extensive clinical experience have contributed to this publication, providing an in-depth overview of the latest knowledge in this field.
Author |
: Brian A. Baldo |
Publisher |
: Springer |
Total Pages |
: 623 |
Release |
: 2016-08-12 |
ISBN-10 |
: 9783319304724 |
ISBN-13 |
: 3319304720 |
Rating |
: 4/5 (24 Downloads) |
Synopsis Safety of Biologics Therapy by : Brian A. Baldo
This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.
Author |
: Institute of Medicine |
Publisher |
: National Academies Press |
Total Pages |
: 432 |
Release |
: 2012-10-13 |
ISBN-10 |
: 9780309225496 |
ISBN-13 |
: 0309225493 |
Rating |
: 4/5 (96 Downloads) |
Synopsis Safe and Effective Medicines for Children by : Institute of Medicine
The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.
Author |
: D. K. Peters |
Publisher |
: Wiley-Blackwell |
Total Pages |
: 0 |
Release |
: 1992-12-31 |
ISBN-10 |
: 0632030070 |
ISBN-13 |
: 9780632030071 |
Rating |
: 4/5 (70 Downloads) |
Synopsis Clinical Aspects of Immunology by : D. K. Peters
Author |
: Institute of Medicine |
Publisher |
: National Academies Press |
Total Pages |
: 442 |
Release |
: 2011-04-03 |
ISBN-10 |
: 9780309158060 |
ISBN-13 |
: 0309158060 |
Rating |
: 4/5 (60 Downloads) |
Synopsis Rare Diseases and Orphan Products by : Institute of Medicine
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Author |
: Iqbal Ramzan |
Publisher |
: John Wiley & Sons |
Total Pages |
: 328 |
Release |
: 2021-02-03 |
ISBN-10 |
: 9781119564652 |
ISBN-13 |
: 1119564654 |
Rating |
: 4/5 (52 Downloads) |
Synopsis Biologics, Biosimilars, and Biobetters by : Iqbal Ramzan
A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists
Author |
: Philip Conaghan |
Publisher |
: Oxford University Press |
Total Pages |
: 1553 |
Release |
: 2013-10 |
ISBN-10 |
: 9780199642489 |
ISBN-13 |
: 0199642486 |
Rating |
: 4/5 (89 Downloads) |
Synopsis Oxford Textbook of Rheumatology by : Philip Conaghan
A strong clinical emphasis is present throughout this volume from the first section of commonly presenting problems through to the section addressing problems shared with a range of other clinical sub-specialties.
Author |
: Agency for Healthcare Research and Quality/AHRQ |
Publisher |
: Government Printing Office |
Total Pages |
: 385 |
Release |
: 2014-04-01 |
ISBN-10 |
: 9781587634338 |
ISBN-13 |
: 1587634333 |
Rating |
: 4/5 (38 Downloads) |
Synopsis Registries for Evaluating Patient Outcomes by : Agency for Healthcare Research and Quality/AHRQ
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.
Author |
: Kian Fan Chung |
Publisher |
: European Respiratory Society |
Total Pages |
: 365 |
Release |
: 2019-06-01 |
ISBN-10 |
: 9781849841047 |
ISBN-13 |
: 1849841047 |
Rating |
: 4/5 (47 Downloads) |
Synopsis Severe Asthma by : Kian Fan Chung
Severe asthma is a form of asthma that responds poorly to currently available medication, and its patients represent those with greatest unmet needs. In the last 10 years, substantial progress has been made in terms of understanding some of the mechanisms that drive severe asthma; there have also been concomitant advances in the recognition of specific molecular phenotypes. This ERS Monograph covers all aspects of severe asthma – epidemiology, diagnosis, mechanisms, treatment and management – but has a particular focus on recent understanding of mechanistic heterogeneity based on an analytic approach using various ‘omics platforms applied to clinically well-defined asthma cohorts. How these advances have led to improved management targets is also emphasised. This book brings together the clinical and scientific expertise of those from around the world who are collaborating to solve the problem of severe asthma.
Author |
: Brian A. Baldo |
Publisher |
: Springer |
Total Pages |
: 0 |
Release |
: 2016-05-24 |
ISBN-10 |
: 1493963902 |
ISBN-13 |
: 9781493963904 |
Rating |
: 4/5 (02 Downloads) |
Synopsis Drug Allergy by : Brian A. Baldo
The variety of chemically diverse pharmacological agents administered to patients is large and continues to expand and with every new drug released, there is always potential for adverse reactions, some of them allergic. With its roots in immunology and pharmacology, the science of drug allergy is becoming better understood and applied as its importance is increasingly recognized throughout the many branches of medicine. Drug Allergy: Clinical Aspects, Diagnosis, Mechanisms, Structure-Activity Relationships sheds new light on this field. Comprehensive in design, this authoritative title identifies the most important culprit drugs implicated in immediate and delayed drug hypersensitivities and offers up-to-date information on classifications, diagnoses, underlying mechanisms and structure-activity relationships. Chapters dealing with the molecular and cellular mechanisms of drug hypersensitivities, non-immune-mediated sensitivities and diagnostic methods are presented as introductory material for in-depth treatises on the β-lactam antibiotics, other antibiotics and antimicrobials, drugs used in anesthesia and surgery, opioid analgesics, corticosteroids, monoclonal antibodies and other biologics, drugs used in chemotherapy, proton pump inhibitors, iodinated and gadolinium-based contrast media and non-steroidal anti-inflammatory drugs. In addition to being of immense value to clinicians, other health care professionals and researchers, this title will prove invaluable for those taking undergraduate and graduate courses in science and will also serve as a useful text for students of medicine, pharmacy, nursing and dentistry.